Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04QVX
|
|||
Former ID |
DNC007416
|
|||
Drug Name |
N-(5-methylthiazol-2-yl)benzamide
|
|||
Synonyms |
N-(5-methyl-1,3-thiazol-2-yl)benzamide; AC1MBAM0; SCHEMBL1270133; CHEMBL390097; MolPort-006-054-218; ZINC3555837; STL456150; AKOS008918901; MCULE-4605210896; KB-102415; N-(5-Methylthiazol-2-yl)benzenecarboxamide; N~1~-(5-methyl-1,3-thiazol-2-yl)benzamide; Z29325335
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H10N2OS
|
|||
Canonical SMILES |
CC1=CN=C(S1)NC(=O)C2=CC=CC=C2
|
|||
InChI |
1S/C11H10N2OS/c1-8-7-12-11(15-8)13-10(14)9-5-3-2-4-6-9/h2-7H,1H3,(H,12,13,14)
|
|||
InChIKey |
HEGBNFORMCPFKO-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | LOX-5 messenger RNA (ALOX5 mRNA) | Target Info | Inhibitor | [1] |
BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
Resolvin D biosynthesis | ||||
Leukotriene biosynthesis | ||||
Lipoxin biosynthesis | ||||
Aspirin triggered resolvin D biosynthesis | ||||
Aspirin triggered resolvin E biosynthesis | ||||
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Serotonergic synapse | ||||
Ovarian steroidogenesis | ||||
Toxoplasmosis | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Arachidonic acid metabolism | |||
Eicosanoid Synthesis | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.